• Article highlight
  • Article tables
  • Article images

Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1235

PDF Downloaded: 738


Get Permission Sachdeva, Parekh, Malawat, Jethava, and Mansuri: Comparison of intrathecal dexmedetomidine and intrathecal fentanyl as an adjuvant with hyperbaric bupivacaine for spinal anaesthesia in lower limb surgeries: A prospective randomized clinical trial


Introduction

There are various anaesthetic modalities for the execution of lower limb surgeries; such as local infiltration, neuraxial blocks and general anaesthesia. Out of which, the neuraxial block is the most preferred technique. Spinal anaesthesia has the advantages of rapid onset, dense block, reducing stress responses, avoiding postoperative pulmonary complications, reducing chances of deep vein thrombosis in addition to being cost-effective. However, the limited duration of intrathecal local anaesthetics is a major concern, which necessitates the administration of post-operative analgesics.1, 2

Additions of various agents to intrathecally administered local anaesthetics have been proved to prolong the effective analgesic duration along with a reduction in systemic analgesia consumption and demands.3 Some of the agents used successfully as an adjuvant to intrathecal anaesthetics includes opioids, α2 agonists, vasoconstrictors, neostigmine, magnesium sulpate, etc.

α2 agonists such as clonidine and dexmedetomidine act on presynaptic and postsynaptic α2 receptors.4 Dexmedetomidine offers anxiolysis, analgesia, sedation, neuroprotection, and anaesthetic-sparing profile. It is due to all these advantages, dexmedetomidine drastically enhance the analgesic duration in epidural block, spinal block and caudal block as well.5, 6, 7

Fentanyl belongs to the class of synthetic opioids which has a central action. Intrathecal fentanyl not only lowers the dose requirement of local anaesthetics but also improves the overall analgesic property of the local anesthetic at the cost of minimal or insignificant side effects.8

In this study, we compared and evaluated the perioperative effective profile of dexmedetomidine and fentanyl as an adjuvant to intrathecally administered hyperbaric bupivacaine in patients posted electively for operative procedures of lower extremity under subarachnoid block.

Materials and Methods

This prospective double-blind, randomized study was conducted at orthopedic operation theatre of Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan after due clearance and permission from institutional ethics committee. During the preanaesthetic evaluation, all the patients were elaborately informed about the study procedure along with the advantage, and the disadvantages and that they have the right to deny. Thereafter, consent for same was taken and those denying the consent were not included in the study.

Ninety patients aged 18-60 years belonging to the physical status class either I or II of American Society of Anaesthesiologists (ASA) and posted for elective lower extremity operative procedure under subarachnoid block were enrolled in the study. Exclusion criteria were patients with severe anemia, compromised cardiopulmonary status, haemodynamic instability, mental instability, and any obvious drug allergy. Similarly, unwilling, non-cooperative patients and patients requiring emergency surgical procedures were not included in the study.

All the patients fulfilling the inclusion criteria were enrolled in the study and divided into two equal groups (Group BD and Group BF). The group assignment was done randomly with help of a computer-generated list. Allocation of specific group was done using a sealed opaque envelope to maintain better concealment of allocation sequence. The opaque sealed envelope was subsequently opened by an anaesthesiologist who although was responsible for preparation of the desired drug solution as per the randomization but, was not directly involved in the study process. The anaesthesiologist responsible for performing the block procedure and observing the study outcomes was blinded to the group treatment. Anaesthesiologist responsible for data collection was also unaware of the group allocation. Patients of group BD received combination of hyperbaric bupivacaine (0.5%) 12.5 mg and dexmedetomidine 5 mcg. Patients of group BF received combination of hyperbaric bupivacaine (0.5%) 12.5 mg and fentanyl 25 mcg.

All the patients were visited and evaluated thoroughly a day before the surgery. All the patients were prescribed oral alprazolam 0.5 mg for the night before surgery.

On the operative day, standard ASA monitoring including the 5 leads echocardiography, non-invasive blood pressure, and oxygen saturation with pulse oximetry were connected and baseline vital parameters were noted. Venous access was secured using an 18 G cannula on the dorsum of the limb opposite to that undergoing surgery. Using all aseptic precautions, patient was positioned in left lateral position and subarachnoid block was performed by lumbar puncture at L3-L4 interspace level using a 25G standard spinal needle. The study drug was carefully administered into the intrathecally after aspiration of the free flow of clear cerebro-spinal fluid with the operating table being flat. Immediately after injection of the entire study drug, the patients were turned supine and supplemental oxygen was provided to all the enrolled patients through a nasal cannula at 4 L/min.

Each patient was assessed at various predetermined time-points for 3 hours post-spinal injection of test drugs for assessment of various outcome measures.

Evaluation of sensory and motor block was done at an interval of 5 min after block execution until half-hour and then every half hourly interval post completion of operative procedure or until the block had completely worn off.

Evaluation of sensory block with sensation to pin-prick on a 3-point scale was done

  1. No block at all

  2. Appreciation of loss of sensation to pin-prick

  3. Complete absence of tactile sensation.

Evaluation of motor block was done by using modified bromage scale:

  1. Complete absence of paralysis

  2. Difficulty to elevate the extended knee

  3. Difficulty in knee flexion

  4. Difficulty in ankle joint flexion.

A complete block was defined as grade-3 sensory block and motor block as well. Patients achieving complete block criteria were considered for further study. Patients with a sensory block of grade-1, 2 or motor block of grade-0, 1 and 2 were considered as block failure and were converted to general anaesthesia and hence were excluded from further analysis.

Evaluation of haemodynamic stability in terms of pulse rate, systolic blood pressure, and diastolic blood pressure

Evaluati

on of analgesic demands in the immediate postoperative period with the visual analogue scale (VAS) score.

Post-operative pain was analyzed using a visual analogue scale (VAS) (where, 0 denotes ‘no pain’ while, 10 denotes ‘worst possible pain’) for every hourly until the block worn off completely. Rescue analgesia was considered using diclofenac sodium 75 mg intramuscularly when VAS ≥4.

Evaluation of complications in perioperative period (bradycardia, hypotension, respiratory depression, etc was also recorded

  1. Bradycardia was defined as one-fifth decrease from the baseline value or an absolute heart rate <50 beats per min; which was treated by atropine 1 ml bolus intravenously.

  2. Hypotension was defined as one-fifth decrease from the baseline or an absolute mean blood pressure <60 mmHg; which was treated by administration of IV crystalloids (200 ml bolus) or incremental dosage of mephentermine 3 mg IV.

  3. Respiratory depression was defined as SpO2 < 90% on room air; which was treated by the supplementation of oxygen through a nasal cannula at 4 L/min.

  4. Shivering; which was treated by administration of IV tramadol 0.5 mg/kg.

  5. Nausea and vomiting; was treated by administration of IV ondansetron 4 mg.

Statistical analyses

Assuming, a 30 min difference in prolongation of sensory analgesia with 90% study power along with type I error (α = 0.05) and type II error (β) at 0.1, the sample size of 43 patients in each group was obtained. For better evaluation of outcome measures we considered 45 patients in each group.

Statistical analysis was executed using SPSS, version 19.0 for Windows statistical software package (SPSS Inc, Chicago, IL, USA). A chi-square test was applied for age, sex, and ASA grades. Unpaired t-test was considered for the remaining parameters of the demographic data, all the haemodynamic parameters, sensory/motor block onset and duration, and analgesic duration. P-value was considered significant if <0.05 and highly significant if <0.001.

Results

A total of ninety patients were enrolled in our study and none were excluded as shown in the consort chart [Figure 1]. Demographic data, hemodynamic parameters, sensory and motor block onset time, two-segmental sensory regression time, and average block and analgesic duration, and perioperative complications (intraoperative and postoperative) were evaluated for each patient. Demographic parameters were comparable among both the groups [Table 1].

The sensory block onset was comparatively faster in Group BD than Group BF (6.95 ± 1.82 min vs. 7.37 ± 2.40 min), while the motor block onset was found to be earlier with Group BF in comparison to Group BD (12.00 ± 1.27 min vs. 12.04 ± 1.79 min). However, the differences with the sensory and motor block onset remained statistically insignificant (P = 0.4988 and 0.4918) [Table 2].

The two-segmental sensory regression time and time for regression to L1 dermatome was significantly less in Group BF (75.80 ± 8.56 min and 111.95 ± 8.06 min) than Group BD (103.11 ± 13.45 min and 129.91 ± 10.45 min); (P<0.00001) [Table 2].

The motor block duration was increased in Group BF than Group BD (156.62 ± 13.30 min vs.150.20 ± 13.77 min), and this difference was also statistically insignificant (P =0.6660). The analgesic demand in the immediate postoperative period was statistically insignificant among both the groups (P = 0.0907) [Table 2].

The haemodynamic parameters were well preserved within the presumed range of significant variation, i.e., 20% from baseline throughout the surgery. Statistically insignificant difference were found in haemodynamic variables among both the groups at any time point [Table 3, Table 4, Table 5, Table 6].

The incidences of perioperative complications were higher in Group BD in comparison to Group BF; hypotension (17.7% vs. 11.1%), bradycardia (5.5% vs. 13.3%), shivering (11.1% vs. 8.8%) [Table 7]. Out of the total fourty five participants included in each study group, none had to be dropped off.

Figure 1

Consort flow diagram

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/a50f4eb9-507f-4031-9722-f8757a858d14/image/d18eaa79-273d-46b9-a76d-bed77f9dbe9c-uimage.png

Table 1

Distribution of demographic data among the studied groups

Parameters Mean±SD
Group BD (n=45) Group BF (n=45)
Age (years) .4±13.5 29.2±14.3 0.785*
Sex (%)
Male 40 39 0.606*
Female 5 6
Weight (kg) 68.8±7.4 66.2±7.9 0.110#
Duration of surgery (min) 132±9.4 134±10.6 0.346#
ASA grade (%)
I 32 31 0.606*
II 13 14

[i] *Chi-square test; #Unpaired t‑test. n – Number ofpatients; SD – Standard deviation; ASA – American Society of Anesthesiologists

Table 2

Comparison of block outcomes in between the groups

Group BD Group BF P*
Mean SD SE Range Mean SD SE Range
Onset of sensory block 6.95 1.82 0.27 4.0-12.0 7.37 2.4 0.35 4.0-12.0 0.498
Onset of motor block 12.04 1.79 0.26 9.0-17.0 12 1.27 0.19 9.0-15.0 0.491
Mean time for two segment sensory regression 103.11 13.45 2 75.0-135.0 75.8 8.56 1.27 60.0-95.0 <0.00001
Mean time for regression to L1 dermatome 129.91 10.45 1.55 96.0-145.0 111.95 8.06 1.2 92.0-128.0 <0.00001
Duration of motor block 150.2 13.77 2.05 112.0-174.0 156.62 13.3 1.98 109.0-175.0 0.666

[i] *Unpaired t‑test. SD – Standard deviation, SE –Standard error.

Table 3

Comparison of heart rate in different time interval in between groups

Heart Rate Group BD Group BF P*
Mean SD Mean SD
Baseline 73.2 5.2 74.3 5.4 0.327
Immediately after block 73.6 6.7 71.8 5.6 0.170
5 min after block 69.6 4.8 70.1 3.9 0.589
10 min 70.8 4.3 70.6 4.9 0.837
20 min 74.2 4.2 73.3 4.4 0.323
30 min 73 5.3 72.8 4.6 0.848
1 hour 73.4 5.8 71.2 4.9 0.055
At end of surgery 73.2 4.9 74.6 4.1 0.145

[i] *Unpaired t‑test. SD – Standard deviation

Table 4

Comparison of SBP indifferent time interval in between groups

Group BD Group BF P*
Mean SD Mean SD
Baseline 128.4 4.6 127 4.8 0.161
Immediately after block 124.3 6.9 125.1 4.9 0.527
5 min after block 119.9 5.4 120.5 5.8 0.612
10 min 122.6 5.6 123.4 5.2 0.484
20 min 128.4 4.9 125.9 9.5 0.120
30 min 128.7 6.2 126.8 6.5 0.159
1 hour 126.9 5.9 125.2 13.4 0.438
At end of surgery 125.4 6.1 126.3 5.9 0.478

[i] *Unpaired t‑test. SBP – Systolic blood pressure, SD - Standard deviation

Table 5

Comparison of DBP in different time interval in between groups

DBP Group BD Group BF P*
Mean SD Mean SD
Baseline 82.4 7.8 84.8 7.2 0.132
Immediately after block 81.3 7.4 83.2 5.9 0.181
5 min after block 80.4 7.3 79.9 8.4 0.763
10 min 81.3 7.9 79.7 7.2 0.318
20 min 84.5 6.9 81.4 8.4 0.059
30 min 82.3 7.5 80.9 5.9 0.327
1 hour 81.6 5.9 79.8 6.1 0.158
At end of surgery 82.8 6.1 81.3 5.8 0.235

[i] *Unpaired t‑test. DBP – Dystolic blood pressure, SD - Standard deviation

Table 6

Comparison of MBP in different time interval in between groups

MBP Group BD Group BF P*
Mean SD Mean SD
Baseline 94.5 2.9 95.3 3.1 0.209
Immediately after block 93.8 3.8 95.2 3.2 0.062
5 min after block 96.4 3.7 95.8 3.9 0.456
10 min 94.4 3.4 93.2 4.2 0.139
20 min 93.5 3.6 94.2 4.1 0.391
30 min 92.7 3.8 91.9 3.9 0.327
1 hour 94.5 4.2 95.4 4.9 0.352
At end of surgery 93.7 4.1 92.8 4.4 0.318

[i] *Unpaired t‑test. MBP – Mean blood pressure, SD - Standard deviation

Table 7

Distribution of complications

Group BD (n=45) Group BF (n=45)
Intraoperative complications
Hypotension 17.70% 11.11%
Bradycardia 15.50% 13.33%
Shivering 11.11% 8.89%
Itching 4.44% 8.89%
Nausea 11.11% 11.11%
Postoperative side effects
Hypotension 6.67% 0.00%
Headache 6.67% 0.00%
Shivering 2.22% 2.22%
Nausea 2.22% 2.22%

Discussion

In the current study, we compared and evaluated the perioperative effective profile of dexmedetomidine and fentanyl as an adjuvant to intrathecally administered hyperbaric bupivacaine in patients posted electively for operative procedures of lower extremity under subarachnoid block.

The time to sensory block onset was found to be compartively less in dexmedetomidine group. On the contrary, the time to motor block onset was found to be less in fentanyl group. However, the differences with both the sensory as well as motor block onset remained statistically insignificant between both the groups.

Mahendru et al.9 also found statistically insignificant difference in the motor block onset between dexmedetomidine and fentanyl groups. Various other studies have also reported a relatively rapid sensory block onset with dexmedetomidine.9, 10, 11, 12, 13, 14, 15, 16 All these results were in conjunction with observations of our study. While Yektas et al.10 Ravipati et al.12 reported rapid motor block onset with dexmedetomidine.

The exact mechanism behind property of dexmedetomidine in escalating both the sensory as well as motor block is not yet known. Selective α2 agonist activity of dexmedetomidine provides surplus analgesia by suppressing the release of transmitters of type C fiber and by causing hyperpolarization of the neurons post-synaptically.10

None of the patients required analgesics during the intraoperative period.

The mean time for two segments of sensory regression and regression to L1 dermatome was significantly longer when dexmedetomidine was used as an adjuvant instead of fentanyl to hyperbaric bupivacaine. While the opposite effect was seen with motor block duration being was higher with fentanyl instead of dexmedetomidine. Reduced requirement of postoperative analgesics with stable haemodynamic parameters along with significantly heightened sensory and motor block with dexmedetomidine have been reported in several other studies comparing dexmedetomidine with a variety of other drugs such as clonidine, fentanyl, and sufentanil.13, 16, 17, 18, 19, 20 Various studies have claimed better results with dexmedetomidine in comparison to fentanyl especially in orthopedic operative cases of the lower extemity. 9, 10

The haemodynamic parameters were found to be well maintained without any significant difference in both the groups. Similarly, other studies did not report any statistically significant difference between fentanyl and dexmedetomidine regarding haemodynamic status.9, 10, 12, 13, 14, 15

Bradycardia and hypotension are generally associated with opioid administration. The variation in haemodynamic parameters can be justified owing to the individual response to the drug, the injectate volume and diluent used. Side effects may occur with any anaesthesia medication but, the quality of the best medication is the highest efficacy with the lowest side effects. Although we observed increased incidences of hypotension and shivering with dexmedetomidine and bradycardia with fentanyl; but the ratio was minimal and insignificant.

To attain better effective profile, increment in dose of the dexmedetomidine can be attempted. Gupta et al.16 reported that dexmedetomidine dose increment from 2.5 mcg to 10 mcg offers superior quality of sensory as well as motor block at cost of minimal or no side effects.

Conclusion

In conclusion, addition of dexmedetomidine as an adjuvant to intrathecally administered hyperbaric bupivacaine offers a significantly heightened of sensory and motor block duration, and superior perioperative analgesia with utmost haemodynamic stability and minimal side effects.

Source of Funding

None.

Conflict of Interest

None.

References

1 

N Elia X Culebras C Mazza E Schiffer M R Tramèr Clonidine as an adjuvant to intrathecal local anesthetics for surgery: systematic review of randomized trialsReg Anesth Pain Med200833215967

2 

M Boussofara M Carlès M Raucoules-Aimé M R Sellam J L Horn Effects of intrathecal midazolam on postoperative analgesia when added to a bupivacaine-clonidine mixtureReg Anesth Pain Med20063165015

3 

S H Faiz P Rahimzadeh M Sakhaei F Imani P Derakhshan Anesthetic effects of adding intrathecal neostigmine or magnesium sulphate to bupivacaine in patients under lower extremities surgeriesJ Res Med Sci2012171091822

4 

Alka Shah Ila Patel Rachana Gandhi Haemodynamic effects of intrathecal dexmedetomidine added to ropivacaine intraoperatively and for postoperative analgesiaInt J Basic Clin Pharmacol2013212692319-2003Medip Academy

5 

Oliver Panzer Vivek Moitra Robert N. Sladen Pharmacology of Sedative-Analgesic Agents: Dexmedetomidine, Remifentanil, Ketamine, Volatile Anesthetics, and the Role of Peripheral Mu AntagonistsCrit Care Clin2009253451690749-0704Elsevier BV

6 

Alex Bekker Mary Sturaitis Marc Bloom Mario Moric John Golfinos Erik Parker Ramesh Babu Abishabeck Pitti The Effect of Dexmedetomidine on Perioperative Hemodynamics in Patients Undergoing CraniotomyAnesth Analg20081074134070003-2999Ovid Technologies (Wolters Kluwer Health)

7 

SS Harsoor K Sudheesh Dexmedetomidine in anaesthesia practice: A wonder drug?Indian J Anaesth201155432340019-5049Medknow

8 

S S Liu S B McDonald Current issues in spinal anesthesiaAnesthesiol2001945888906

9 

Vidhi Mahendru Anurag Tewari Sunil Katyal Anju Grewal MRupinder Singh Roohi Katyal A comparison of intrathecal dexmedetomidine, clonidine, and fentanyl as adjuvants to hyperbaric bupivacaine for lower limb surgery: A double blind controlled studyJ Anaesthesiol Clin Pharmacol201329449620970-9185Medknow

10 

A Yektas E Belli The effects of 2 μg and 4 μg doses of dexmedetomidine in combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its postoperative analgesic characteristicsPain Res Manag20141927581

11 

D Machin M J Campbell S-B Tan S-H Tan Sample size tables for clinical studiesJohn Wiley & Sons2011

12 

Prabhavathi Ravipati GAnand Isaac PNarasimha Reddy Leela Krishna T Supritha A comparative study between intrathecal isobaric ropivacaine 0.75% plus dexmedetomidine and isobaric ropivacaine 0.75% plus fentanyl for lower limb surgeriesAnesth Essays Res201711362160259-1162Medknow

13 

G. E. Kanazi M. T. Aouad S. I. Jabbour-Khoury M. D. Al Jazzar M. M. Alameddine R. Al-Yaman Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal blockActa Anaesthesiol Scand20065022227

14 

X Y Niu X B Ding T Guo M H Chen S K Fu Q Li Effects of intravenous and intrathecal Dexmedetomidine in spinal anesthesia: a meta-analysisCNS Neurosci Ther20131911897904

15 

RajBahadur Singh RajniK Tripathi Sanjay Choubey AamirLaique Khan A comparative study between intrathecal dexmedetomidine and fentanyl as adjuvant to intrathecal bupivacaine in lower abdominal surgeries: A randomized trialAnesthesia: Essays and Researches2015921391390259-116210.4103/0259-1162.156284Medknowhttps://dx.doi.org/10.4103/0259-1162.156284

16 

M Gupta P Gupta D K Singh Effect of 3 different doses of intrathecal Dexmedetomidine (2.5μg, 5μg, and 10 μg) on subarachnoid block characteristics: a prospective randomized double blind dose-response trialPain Physician2016193411431

17 

Claes Post Torsten Gordh jr Bruce G. Minor Trevor Archer Jacob Freedman Antinociceptive Effects and Spinal Cord Tissue Concentrations after Intrathecal Injection of Guanfacine or Clonidine into RatsAnesth Analg1987664317240003-2999Ovid Technologies (Wolters Kluwer Health)

18 

Subhi M. Al-Ghanem Islam M. Massad Mahmoud M. Al-Mustaf Khaled R. Al-Zaben Ibrahim Y. Qudaisa Ayman M. Qatawn Effect of Adding Dexmedetomidine versus Fentanyl to Intrathecal Bupivacaine on Spinal Block Characteristics in Gynecological Procedures: A Double Blind Controlled StudyAm J Appl Sci20096588271546-9239Science Publications

19 

Al-Mustafa Mm Abu-Halaweh S A Aloweidi A S Murshidi M M Ammari B A Awwad Z M Al-Edwan Effect of dexmedetomidine added to spinal bupivacaine for urological proceduresSaudi Med J200930336570

20 

F A Ibrahim A comparative study of adding intrathecal dexmedetomidine versus sufentanil to heavy bupivacaine for postoperative analgesia in patients undergoing inguinal hernia repairBenha M J200926320717



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.